HIV 1 News and Research

RSS

NIH awards Georgia State University $6.7M to commence new Center for Excellence in Health Disparities Research

The National Institutes of Health has awarded Georgia State University with a five-year grant to start a new Center for Excellence in Health Disparities Research, which will investigate health disparity issues in Atlanta's urban environment.

22 Sep 2010

Secretary-General opens U.N. summit on MDGS with appeal for world leaders to maintain target commitments

On the first of the three-day U.N. Summit on the Millennium Development Goals (MDGs), U.N. Secretary-General Ban Ki-moon on Monday appealed "to the assembled presidents, prime ministers and kings to use their power to meet U.N. goals to help the world's poorest by 2015," the Associated Press reports.

22 Sep 2010

Clinton Global Initiative meeting kicks off, U.S. will commit to Clean Cookstove project

"World leaders, CEOs, non-governmental organizations and philanthropists" are gathering this week at the Clinton Global Initiative (CGI) annual meeting, "[t]imed to coincide with the beginning of the United Nations General Assembly," WNYC News reports (Herman, 9/20).

22 Sep 2010

HIV infection mystery revealed

In a new discovery, Melbourne researchers have found a mechanism by which the HIV virus can affect people. According to co-head of the Burnet Institute's Centre for Virology, Sharon Lewin, scientists have found out how HIV entered a group of cells in which the virus tends to persist in spite of antiviral treatment that reduces the virus to undetectable levels.

22 Sep 2010

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats.

21 Sep 2010

Cytheris commences enrollment in CYT107 recombinant human Interleukin-7 clinical trial for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 3, a Phase II clinical program evaluating the effect of repeated cycles of the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non-Responders (INR) after at least 24 months of highly active anti-retroviral therapy (HAART).

21 Sep 2010

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Data from the GRACE study will be published in the September 21st issue of the Annals of Internal Medicine. GRACE is the largest-ever study of treatment experienced adult women with HIV-1 to examine gender differences in response to HIV therapy. Sponsored by Tibotec Therapeutics Clinical Affairs, a division of Centocor Ortho Biotech Services, LLC, the GRACE study enrolled 67 percent women, demonstrating that it is possible to recruit large numbers of women into U.S.-based HIV treatment studies.

21 Sep 2010

International activists ask: 'Will MDG summit fail HIV-positive people?'

A group of Russian AIDS activists are charging that the Russian Ministry of Health is denying that there are drug stock-outs that prevent patients from starting or continuing treatment. "In this situation, people with HIV face a choice: to die quietly at home or try to attract the attention of the government and the media," said Alexey Yaskovich, a Russian activist from Novgorod. "Therefore, activists will continue to go to the streets of Moscow and hold public events dedicated to saving their lives."

21 Sep 2010

Inovio Pharmaceuticals completes enrollment for PENNVAX-B vaccine Phase I clinical study

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the Phase I clinical study assessing Inovio's PENNVAX-B DNA vaccine delivered using its proprietary electroporation technology in a preventive setting has fully completed the enrollment of 48 healthy volunteers. The multi-center study is being conducted by Inovio's clinical collaborator, the HIV Vaccine Trials Network (HVTN), at several clinical sites under a protocol designated HVTN-080.

21 Sep 2010

Global dementia costs hit $604 billion: World Alzheimer Report 2010

The total estimated worldwide costs of dementia are $604 billion in 2010, according to the newly released World Alzheimer Report 2010, The Global Economic Impact of Dementia from Alzheimer's Disease International (ADI), a London based, nonprofit, international federation of 73 national Alzheimer organizations, including the Alzheimer's Association (U.S.).

21 Sep 2010

U.N. MDG summit begins; UNAIDS data shows 22 African countries see drop in new HIV infections

"Ten years after world leaders set the most ambitious goals ever to tackle global poverty, they are meeting again to try to spur action to meet the targets by the 2015 deadline - which the U.N. says will be difficult, if not impossible, in some cases," the Associated Press reports. More than 140 world leaders are scheduled to participate in the three-day U.N. Summit on the Millennium Development Goals (MDGs), which kicks off Monday.

21 Sep 2010

Gov. Paterson vetoes more rent relief for HIV/AIDS patients

Gov. David A. Paterson, D-N.Y., has vetoed a bill to provide increased rent relief for more than 11,000 New Yorkers with HIV and AIDS.

20 Sep 2010

Biomagnetics signs merger agreement with Zhuhai Energy Science and Technology

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, recently announced its management team was flying to China to close its merger with Zhuhai Energy Science and Technology. Biomagnetics Diagnostics is pleased today to announce the signing of the formal merger agreement. All necessary governmental approvals are expected to be completed mid-week.

20 Sep 2010

Abbott to commercialize Celera's CE-marked KIF6 genotyping assay outside U.S.

Celera Corporation and Abbott today announced that they have signed an exclusive distribution agreement to market Celera's CE-marked KIF6 diagnostic test for use on Abbott's CE-marked m2000™ instrument system. The KIF6 genotyping assay detects a genetic marker that may be used in conjunction with clinical evaluation and patient assessment for the identification of individuals at risk for coronary heart disease (CHD), and in patients for whom statin treatment is being considered.

20 Sep 2010

Researchers discover HIV-1 resists AZT drug

Rutgers researchers have discovered how HIV-1, the virus that causes AIDS, resists AZT, a drug widely used to treat AIDS. The scientists, who report their findings in Nature Structural & Molecular Biology, believe their discovery helps researchers understand how important anti-AIDS treatments can fail and could help AIDS researchers develop more effective treatment for the disease.

20 Sep 2010

Male circumcision shown to help prevent HIV transmission

According to a new study published in the Medical Journal of Australia, male circumcision can be seen as a “surgical vaccine” in the fight against heterosexual HIV transmission. The study based on spread of the virus in Africa showed that there was a reduced rate of transmission in regions where male circumcision was the norm.

19 Sep 2010

Immunotherapy accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Immunotherapy (ISSN 1750-743X) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

19 Sep 2010

Study finds mothers' education levels affect child mortality

A study published in the journal Lancet on Friday found that "a mother's education level has a huge, if indirect, effect on the health of her children," the Washington Post reports.

18 Sep 2010

CDC, Epocrates educate healthcare professionals about safe injection practices

The Centers for Disease Control and Prevention and Epocrates, Inc. are educating healthcare professionals about safe injection practices conveniently and effectively on their smartphone devices. Epocrates' EssentialPoints mobile detailing program provides healthcare professionals with key lessons that can be applied directly to patient care.

18 Sep 2010

Proposal by WHO to eliminate AIDS in South Africa is flawed, model shows

In 2008, Reuben Granich and his colleagues at the World Health Organization published a paper in the medical journal The Lancet that proposed a new strategy for combating HIV in South Africa, a country staggered by the virus, with as much as 18 percent of the population estimated to be infected.

18 Sep 2010